Barrett & Company’s Guardant Health GH Stock Holding History

Barrett & Company’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500	Closed	-$13.5K	–	624
2023 Q4	$13.5K	Hold	500	–	–	0.01%	384
2023 Q3	$14.8K	Hold	500	–	–	0.01%	378
2023 Q2	$17.9K	Hold	500	–	–	0.01%	359
2023 Q1	$11.7K	Hold	500	–	–	0.01%	371
2022 Q4	$13.6K	Hold	500	–	–	0.01%	355
2022 Q3	$13.6K	Buy	+500	New	+$25.7K	0.01%	355

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Barrett & Company's GH Position: Q1 2024 in Review

Barrett & Company sold out of Guardant Health (GH) in Q1 2024, closing a stake of 500 shares — an estimated $13.5K sold.

Barrett & Company first reported a position in GH in Q3 2022 and held it in 6 quarters. The position peaked at $17.9K in Q2 2023. 258 funds tracked by Wall St. Rank hold GH as of Q1 2024.

Barrett & Company reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
Barrett & Company sold 500 Guardant Health shares in Q1 2024, an estimated $13.5K.
Barrett & Company first reported a position in Guardant Health in Q3 2022 and held it in 6 quarters.
Barrett & Company's Guardant Health position peaked at $17.9K in Q2 2023.
258 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Barrett & Company's 13F filing for Q1 2024, filed 17 Apr 2024.